In 2018, the global defibrillator market was worth about USD 9.8 billion and is expected to grow to over USD 21.1 billion by 2032, with a steady annual growth rate of 5.7%. North America led the market in 2018, holding nearly 45% of the total market share.

Defibrillator Market Overview:

Defibrillators are life-saving devices used to treat sudden cardiac arrest (SCA) by delivering an electric shock to help the heart return to a normal rhythm. With more people experiencing heart issues, especially outside of hospitals, there's been a push to place defibrillators in public places like schools, malls, hotels, and streets. Many schools are also running awareness programs to teach students how to respond to cardiac emergencies, which is helping to boost the demand for these devices.

Get a Free Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/defibrillator-market-100950

List Of Companies Profiled In Defibrillator Market:

• Asahi Kasei Corporation
• Philips Healthcare
• Defibtech, LLC.
• Cardiac Science
• Stryker
• CU Medical System Inc.
• Medtronic
• Boston Scientific Corporation
• Biotronik
• LivaNova Plc
• Abbott
• Microport
• Other prominent players

Market Segmentation:

By Type:

The market is split into two main types:

Implantable Cardioverter Defibrillators (ICDs) – These are placed inside the body. There are several types:

Single-chamber and dual-chamber ICDs

CRT-Ds (Cardiac Resynchronization Therapy-Defibrillators) – These were the most popular in 2018 due to high usage in developed countries.

Subcutaneous ICDs – Placed under the skin without touching the heart directly.

External Defibrillators – These include:

Automated External Defibrillators (AEDs) – Common in public places and easy for non-medical people to use.

Manual and semi-automatic defibrillators

Wearable defibrillators – Used by patients at risk of heart problems.

By End User:

Hospitals and clinics were the biggest users in 2018, as they deal with a high number of cardiac emergencies.

Public places are expected to see strong growth thanks to rising awareness and new laws requiring AEDs in schools, offices, and other public areas.

Regional Insights:

North America had the highest market share in 2018, with USD 4.41 billion in revenue. The region is seeing more and more defibrillators being placed not just in hospitals but also in public spaces like schools, streets, and train stations. The growing interest in newer types of ICDs, like subcutaneous ones, is also boosting growth.

Europe is expected to remain the second-largest market, while Asia Pacific is growing quickly due to improved healthcare systems and more widespread adoption of defibrillator technology.

Key Industry Updates:

July 2021 – ZOLL Medical received U.S. FDA approval to launch a brain injury monitoring feature on its defibrillators in the U.S., helping doctors make better decisions for trauma patients.

March 2021 – The government of Nova Scotia (Canada) invested USD 700,000 to install AEDs in all public schools, improving emergency response.

April 2020 – Philips restarted the production and delivery of its defibrillators in the U.S. after the FDA lifted restrictions on its Emergency Care and Resuscitation division.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free)

APAC: +91 744 740 1245

Email: [email protected]